Search for dissertations about: "non-nucleoside inhibitor"
Showing result 11 - 15 of 16 swedish dissertations containing the words non-nucleoside inhibitor.
-
11. Studies of drug resistance in minor HIV quasispecies
Abstract : The main objective was to study drug resistance mutations (DRM) in the HIV-1 reverse transcriptase (RT) gene of minor HIV-1 quasispecies, not detectable with standard techniques. Sensitive allele-specific PCR (AS- PCR) and next-generation sequencing (NGS) were developed to study resistance to drugs of relevance in low- and middle-income countries (LMIC); the nucleoside analogue RT inhibitor (NRTI) lamivudine (3TC) and the non-nucleoside RT inhibitors (NNRTIs) efavirenz (EFV) and nevirapine (NVP). READ MORE
-
12. Mutations and migration : molecular and epidemiological aspects of HIV-1 in Sweden
Abstract : The Swedish HIV-1 epidemic is characterized by a wide variation in subtypes due to migration and travel. The aims of this thesis were to investigate molecular methods for estimating time to diagnosis and epidemiological tools for estimating the proportion of undiagnosed individuals with HIV-1 in Sweden, as well as to update the knowledge on transmitted and pre-treatment drug resistance (TDR and PDR) among persons living with HIV-1 in Sweden. READ MORE
-
13. Reverse transcriptase assay for analysis of resistance to anti-HIV drugs and their mechanism of action
Abstract : Reverse transcriptase (RT) is a viral enzyme and one of the main targets for drugs against human immunodeficiency virus (HIV). This work presents a set of sensitive non-radioactive RT assays were developed: standard RT inhibition assay (IC assay); RT binding inhibition assay; RTprotein detection assay and template-primer destruction assay or chain termination assay (CT assay). READ MORE
-
14. From bedside to bench and back : future options for antiretroviral drugs in non-B HIV-1 subtypes
Abstract : HIV-1 drug resistance remains a burden in low- and middle-income countries (LMIC). Regardless of the advances in antiretroviral (ARV) therapy, there is an increase in the trend of acquired and pre-treatment drug resistance mutations (DRM) in LMIC affected by diverse HIV-1 subtypes. READ MORE
-
15. Ultra-deep characterization of viral quasispecies in HIV infection
Abstract : HIV-1 has the ability to rapidly diversify and adapt to changes in its environment, such as evading the host immune response, altering cell tropism, and developing resistance to antiretroviral drugs. Minority HIV-1 variants have been shown to be of clinical significance, especially those with non-nucleoside reverse transcriptase inhibitor (NNRTI) drug resistance mutations or determinants of CXCR4 phenotype (X4-virus). READ MORE